Growth Hormone Axis
GHRH analogs and secretagogues compared without turning hormone changes into health outcomes.
ASK BETTER QUESTIONS
What changes a growth hormone axis evidence decision?
- Which receptor does the peptide act on?
- Is there a current approved product?
- Are outcomes clinical or limited to hormone measurements?
EVIDENCE RECORDS
Growth Hormone Axis evidence records.
Tesamorelin
Tesamorelin has the strongest human evidence in a narrow, labeled population. Evidence from that population should not be generalized to routine weight management.
Open evidence recordSermorelin
Sermorelin has a longer clinical history than many wellness-market peptides, but historical use is not the same as a current approved product or modern outcomes evidence.
Open evidence recordIpamorelin
Ipamorelin has human exposure data, but the evidence base is narrow and does not validate generalized anti-aging or body-composition claims.
Open evidence recordCJC-1295
CJC-1295 can produce measurable endocrine effects, but biomarker changes should not be confused with proven improvement in health outcomes.
Open evidence recordDIRECT COMPARISONS